Crovalimab
( DrugBank: Crovalimab / KEGG DRUG: Crovalimab )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
62 | Paroxysmal nocturnal hemoglobinuria | 33 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
109 | Atypical hemolytic uremic syndrome | 15 |
62. Paroxysmal nocturnal hemoglobinuria
Clinical trials : 358 / Drugs : 160 - (DrugBank : 35) / Drug target genes : 33 - Drug target pathways : 116
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
109. Atypical hemolytic uremic syndrome
Clinical trials : 123 / Drugs : 29 - (DrugBank : 6) / Drug target genes : 2 - Drug target pathways : 11
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|